Trends in antidiabetic drug discovery: FDA approved drugs, new drugs in clinical trials and global sales
AD Dahlén, G Dashi, I Maslov, MM Attwood… - Frontiers in …, 2022 - frontiersin.org
Type 2 diabetes mellitus (T2DM) continues to be a substantial medical problem due to its
increasing global prevalence and because chronic hyperglycemic states are closely linked …
increasing global prevalence and because chronic hyperglycemic states are closely linked …
Pharmacotherapy of type 2 diabetes: An update and future directions
A DeMarsilis, N Reddy, C Boutari, A Filippaios… - Metabolism, 2022 - Elsevier
Abstract Type 2 diabetes (T2D) is a widely prevalent disease with substantial economic and
social impact for which multiple conventional and novel pharmacotherapies are currently …
social impact for which multiple conventional and novel pharmacotherapies are currently …
Glioma diagnosis and therapy: current challenges and nanomaterial-based solutions
Glioma is often referred to as one of the most dreadful central nervous system (CNS)-specific
tumors with rapidly-proliferating cancerous glial cells, accounting for nearly half of the brain …
tumors with rapidly-proliferating cancerous glial cells, accounting for nearly half of the brain …
Function and structure of bradykinin receptor 2 for drug discovery
J Shen, H Zhang - Acta Pharmacologica Sinica, 2023 - nature.com
Type 2 bradykinin receptor (B2R) is an essential G protein-coupled receptor (GPCR) that
regulates the cardiovascular system as a vasodepressor. Dysfunction of B2R is also closely …
regulates the cardiovascular system as a vasodepressor. Dysfunction of B2R is also closely …
A comprehensive review on current understanding of bradykinin in COVID-19 and inflammatory diseases
DAB Rex, N Vaid, K Deepak, S Dagamajalu… - Molecular Biology …, 2022 - Springer
Bradykinin, a member of the kallikrein–kinin system (KKS), is a potent, short-lived vasoactive
peptide that acts as a vasodilator and an inflammatory mediator in a number of signaling …
peptide that acts as a vasodilator and an inflammatory mediator in a number of signaling …
A modular map of Bradykinin-mediated inflammatory signaling network
DAB Rex, K Deepak, N Vaid, S Dagamajalu… - Journal of Cell …, 2022 - Springer
Bradykinin, a member of the kallikrein-kinin system (KKS), is associated with an
inflammatory response pathway with diverse vascular permeability functions, including …
inflammatory response pathway with diverse vascular permeability functions, including …
Kinins and their B1 and B2 receptors as potential therapeutic targets for pain relief
I Brusco, MFP Fialho, G Becker, ES Brum, A Favarin… - Life Sciences, 2023 - Elsevier
Kinins are endogenous peptides that belong to the kallikrein-kinin system, which has been
extensively studied for over a century. Their essential role in multiple physiological and …
extensively studied for over a century. Their essential role in multiple physiological and …
Mechanisms involved in hereditary angioedema with normal C1-inhibitor activity
Patients with the inherited disorder hereditary angioedema (HAE) suffer from episodes of
soft tissue swelling due to excessive bradykinin production. In most cases, dysregulation of …
soft tissue swelling due to excessive bradykinin production. In most cases, dysregulation of …
Cryo-EM structures of human bradykinin receptor-Gq proteins complexes
The type 2 bradykinin receptor (B2R) is a G protein-coupled receptor (GPCR) in the
cardiovascular system, and the dysfunction of B2R leads to inflammation, hereditary …
cardiovascular system, and the dysfunction of B2R leads to inflammation, hereditary …
A brief review of reporter gene imaging in oncolytic virotherapy and gene therapy
SJ Russell, KW Peng - Molecular Therapy-Oncolytics, 2021 - cell.com
Reporter gene imaging (RGI) can accelerate development timelines for gene and viral
therapies by facilitating rapid and noninvasive in vivo studies to determine the …
therapies by facilitating rapid and noninvasive in vivo studies to determine the …